In addition, blocking the recruitment of monocytes to the tumor by targeting the CC-chemokine ligand 2 (CCL2)–CC-chemokine receptor, showed a reduction in tumor growth and less metastasis in a mouse model of PC (Sanford et al., 2013; Hu et al., 2019). This evidence concerns the gene CCL2 and neoplasm.